We are live on ! Find out more
INSP icon

Inspire Medical Systems

407 hedge funds and large institutions have $9.11B invested in Inspire Medical Systems in 2023 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 124 increasing their positions, 140 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 87 | Existing positions closed: 51

57% more funds holding in top 10

Funds holding in top 10: 711 (+4)

36% more capital invested

Capital invested by funds: $6.68B → $9.11B (+$2.43B)

9% more funds holding

Funds holding: 373407 (+34)

5% more call options, than puts

Call options by funds: $76.8M | Put options by funds: $73.3M

2.59% less ownership

Funds ownership: 98.88%96.29% (-2.6%)

11% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 140

Holders
407
Holders Change
+34
Holders Change %
+9.12%
% of All Funds
6.39%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.17%
New
87
Increased
124
Reduced
140
Closed
51
Calls
$76.8M
Puts
$73.3M
Net Calls
+$3.46M
Net Calls Change
-$587K
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
251
Azzad Asset Management
Virginia
$632K +$557K +1,948 New
RJFSA
252
Raymond James Financial Services Advisors
Florida
$625K -$460K -1,610 -46%
FHB
253
First Hawaiian Bank
Hawaii
$609K -$180K -631 -25%
CCIA
254
Campbell & Co Investment Adviser
Maryland
$606K -$1.13M -3,959 -68%
Corient Private Wealth
255
Corient Private Wealth
Florida
$595K +$524K +1,834 New
NRD
256
Nebula Research & Development
New York
$586K +$516K +1,806 New
FA
257
FDx Advisors
Illinois
$586K +$516K +1,805 New
VIA
258
Virtus Investment Advisers
Connecticut
$585K
KWM
259
Keebeck Wealth Management
Illinois
$581K +$511K +1,789 New
WMSA
260
Weiss Multi-Strategy Advisers
New York
$577K -$53.7K -188 -10%
Twin Tree Management
261
Twin Tree Management
Texas
$574K +$98.6K +345 +24%
MIM
262
MetLife Investment Management
New Jersey
$573K -$3.78M -13,227 -88%
BFG
263
Berger Financial Group
Minnesota
$545K +$480K +1,680 New
PI
264
PFS Investments
Georgia
$530K +$41.7K +146 +10%
Robeco Institutional Asset Management
265
Robeco Institutional Asset Management
Netherlands
$528K
Fifth Third Bancorp
266
Fifth Third Bancorp
Ohio
$520K -$24.9K -87 -5%
URS
267
Utah Retirement Systems
Utah
$504K +$443K +1,552 New
SW
268
SkyOak Wealth
Michigan
$483K +$140K +489 +49%
OSAM
269
O'Shaughnessy Asset Management
Connecticut
$473K +$51.1K +179 +14%
NYLIM
270
New York Life Investment Management
New York
$466K +$410K +1,435 New
LFAS
271
Level Four Advisory Services
Texas
$464K -$305K -1,068 -43%
OHIS
272
Oak Harvest Investment Services
Texas
$450K +$396K +1,385 New
CGH
273
Crossmark Global Holdings
Texas
$440K -$151K -530 -26%
HCM
274
HMS Capital Management
Tennessee
$433K +$381K +1,335 New
NFC
275
Northeast Financial Consultants
Connecticut
$422K

INSP Hedge Fund Activity: Q2 2023 in Review

407 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q2 2023, worth a combined $9.11B — up 36% from $6.68B a quarter earlier.

Buyers outnumbered sellers: 87 funds opened new INSP positions and 51 closed out — a net gain of 36 holders — while 124 added to existing stakes and 140 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $57.7M. The largest seller was BlackRock, cutting an estimated $133M.

  • 407 institutional investors held Inspire Medical Systems (INSP) as of Q2 2023, up from 373 in Q1 2023.
  • Funds reported $9.11B of Inspire Medical Systems stock for Q2 2023, up 36% quarter-over-quarter.
  • 87 funds opened new Inspire Medical Systems positions in Q2 2023 and 51 closed out, a net change of +36 holders.
  • The largest Inspire Medical Systems buyer in Q2 2023 was D.E. Shaw & Co, an estimated $57.7M added.
  • The largest Inspire Medical Systems seller in Q2 2023 was BlackRock, an estimated $133M sold.

Based on aggregated 13F filings for Q2 2023.